Zacks Investment Research
14 May 2026, 13:46 UTC · 26w ago
Verdict
Headline leans bullish. We score CRMD +0.60 across five claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.60strongly bullish
More positive than 78% of ticker scores this week
Search tags
What the story claims
5 claims · scored −1 bearish … +1 bullish
CorMedix reported quarterly revenue of $127.43 million, beating the consensus estimate by 16% and surging 226% from $39.08 million in the year-ago quarter.
More positive than 99% of claims this week
CorMedix posted quarterly adjusted earnings of $0.43 per share, beating the consensus estimate of $0.35 by 24.64%.
So whatA significant positive EPS surprise typically drives immediate upward pressure on the affected stock.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 93% of claims this week
Ahead of this earnings release, the trend for CorMedix's earnings estimate revisions was unfavorable.
More negative than 88% of claims this week
CorMedix shares have lost approximately 35.5% since the beginning of the year, significantly underperforming the S&P 500's 8.8% gain.
More negative than 83% of claims this week
CorMedix missed its prior-quarter EPS estimate by 29.07%, producing $0.61 against expectations of $0.86.
More negative than 75% of claims this week
Which stocks this story touches
More positive than 78% of ticker scores this week
The company beat both earnings and revenue consensus estimates for the quarter.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
1h ago
−30.5%
Price is moving against the score
$5.21 vs $7.50 close before publication (May 13) · not market-adjusted
CRMD chart →
